File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice

TitleBile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice
Authors
KeywordsBile acids
Gut microbiota
High-fat diet
Microbe-metabolite interaction
Obesity
Issue Date2017
Citation
BMC Biology, 2017, v. 15, n. 1, article no. 120 How to Cite?
AbstractBackground: Intestinal bacteria are known to regulate bile acid (BA) homeostasis via intestinal biotransformation of BAs and stimulation of the expression of fibroblast growth factor 19 through intestinal nuclear farnesoid X receptor (FXR). On the other hand, BAs directly regulate the gut microbiota with their strong antimicrobial activities. It remains unclear, however, how mammalian BAs cross-talk with gut microbiome and shape microbial composition in a dynamic and interactive way. Results: We quantitatively profiled small molecule metabolites derived from host-microbial co-metabolism in mice, demonstrating that BAs were the most significant factor correlated with microbial alterations among all types of endogenous metabolites. A high-fat diet (HFD) intervention resulted in a rapid and significant increase in the intestinal BA pool within 12 h, followed by an alteration in microbial composition at 24 h, providing supporting evidence that BAs are major dietary factors regulating gut microbiota. Feeding mice with BAs along with a normal diet induced an obese phenotype and obesity-associated gut microbial composition, similar to HFD-fed mice. Inhibition of hepatic BA biosynthesis under HFD conditions attenuated the HFD-induced gut microbiome alterations. Both inhibition of BAs and direct suppression of microbiota improved obese phenotypes. Conclusions: Our study highlights a liver-BA-gut microbiome metabolic axis that drives significant modifications of BA and microbiota compositions capable of triggering metabolic disorders, suggesting new therapeutic strategies targeting BA metabolism for metabolic diseases.
Persistent Identifierhttp://hdl.handle.net/10722/342552
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZheng, Xiaojiao-
dc.contributor.authorHuang, Fengjie-
dc.contributor.authorZhao, Aihua-
dc.contributor.authorLei, Sha-
dc.contributor.authorZhang, Yunjing-
dc.contributor.authorXie, Guoxiang-
dc.contributor.authorChen, Tianlu-
dc.contributor.authorQu, Chun-
dc.contributor.authorRajani, Cynthia-
dc.contributor.authorDong, Bing-
dc.contributor.authorLi, Defa-
dc.contributor.authorJia, Wei-
dc.date.accessioned2024-04-17T07:04:37Z-
dc.date.available2024-04-17T07:04:37Z-
dc.date.issued2017-
dc.identifier.citationBMC Biology, 2017, v. 15, n. 1, article no. 120-
dc.identifier.urihttp://hdl.handle.net/10722/342552-
dc.description.abstractBackground: Intestinal bacteria are known to regulate bile acid (BA) homeostasis via intestinal biotransformation of BAs and stimulation of the expression of fibroblast growth factor 19 through intestinal nuclear farnesoid X receptor (FXR). On the other hand, BAs directly regulate the gut microbiota with their strong antimicrobial activities. It remains unclear, however, how mammalian BAs cross-talk with gut microbiome and shape microbial composition in a dynamic and interactive way. Results: We quantitatively profiled small molecule metabolites derived from host-microbial co-metabolism in mice, demonstrating that BAs were the most significant factor correlated with microbial alterations among all types of endogenous metabolites. A high-fat diet (HFD) intervention resulted in a rapid and significant increase in the intestinal BA pool within 12 h, followed by an alteration in microbial composition at 24 h, providing supporting evidence that BAs are major dietary factors regulating gut microbiota. Feeding mice with BAs along with a normal diet induced an obese phenotype and obesity-associated gut microbial composition, similar to HFD-fed mice. Inhibition of hepatic BA biosynthesis under HFD conditions attenuated the HFD-induced gut microbiome alterations. Both inhibition of BAs and direct suppression of microbiota improved obese phenotypes. Conclusions: Our study highlights a liver-BA-gut microbiome metabolic axis that drives significant modifications of BA and microbiota compositions capable of triggering metabolic disorders, suggesting new therapeutic strategies targeting BA metabolism for metabolic diseases.-
dc.languageeng-
dc.relation.ispartofBMC Biology-
dc.subjectBile acids-
dc.subjectGut microbiota-
dc.subjectHigh-fat diet-
dc.subjectMicrobe-metabolite interaction-
dc.subjectObesity-
dc.titleBile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1186/s12915-017-0462-7-
dc.identifier.pmid29241453-
dc.identifier.scopuseid_2-s2.0-85041046724-
dc.identifier.volume15-
dc.identifier.issue1-
dc.identifier.spagearticle no. 120-
dc.identifier.epagearticle no. 120-
dc.identifier.eissn1741-7007-
dc.identifier.isiWOS:000418099000002-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats